ZNF391

gene
On this page

Also known as dJ153G14.3

Summary

ZNF391 (zinc finger protein 391, HGNC:18779) is a protein-coding gene on chromosome 6p22.1, encoding Zinc finger protein 391 (Q9UJN7). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 346157 — RefSeq curated summary.

At a glance

  • GWAS associations: 21
  • Clinical variants (ClinVar): 49 total
  • MANE Select transcript: NM_001076781

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18779
Approved symbolZNF391
Namezinc finger protein 391
Location6p22.1
Locus typegene with protein product
StatusApproved
AliasesdJ153G14.3
Ensembl geneENSG00000124613
Ensembl biotypeprotein_coding
Entrez346157

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 8 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000244576, ENST00000461521, ENST00000477999, ENST00000482767, ENST00000901127, ENST00000901128, ENST00000901129, ENST00000937720, ENST00000937721, ENST00000958924

RefSeq mRNA: 4 — MANE Select: NM_001076781 NM_001076781, NM_001322288, NM_001322289, NM_001322293

CCDS: CCDS43429

Canonical transcript exons

ENST00000244576 — 3 exons

ExonStartEnd
ENSE000014265392738875927389075
ENSE000015373912739944227399550
ENSE000017330422740029327403908

Expression profiles

Bgee: expression breadth ubiquitous, 166 present calls, max score 84.35.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2089 / max 65.0649, expressed in 938 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
665670.8998469
665700.8979502
665680.2293110
665690.155780
665660.02627

Top tissues by expression

284 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.35gold quality
right uterine tubeUBERON:000130279.40gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.09gold quality
cerebellar hemisphereUBERON:000224573.84gold quality
prefrontal cortexUBERON:000045173.79gold quality
cerebellar cortexUBERON:000212973.77gold quality
right hemisphere of cerebellumUBERON:001489073.76gold quality
body of pancreasUBERON:000115073.42gold quality
left ovaryUBERON:000211973.25gold quality
right ovaryUBERON:000211872.79gold quality
cortical plateUBERON:000534372.70gold quality
right frontal lobeUBERON:000281072.49gold quality
Brodmann (1909) area 9UBERON:001354072.44gold quality
anterior cingulate cortexUBERON:000983571.87gold quality
cingulate cortexUBERON:000302771.77gold quality
ventricular zoneUBERON:000305371.44gold quality
cerebellumUBERON:000203771.27gold quality
pancreasUBERON:000126471.10gold quality
right lobe of thyroid glandUBERON:000111971.02gold quality
endocervixUBERON:000045870.99gold quality
descending thoracic aortaUBERON:000234570.94gold quality
olfactory segment of nasal mucosaUBERON:000538670.86gold quality
islet of LangerhansUBERON:000000670.71gold quality
right adrenal gland cortexUBERON:003582770.63gold quality
left testisUBERON:000453370.62gold quality
left lobe of thyroid glandUBERON:000112070.61gold quality
right testisUBERON:000453470.57gold quality
right coronary arteryUBERON:000162570.53gold quality
ganglionic eminenceUBERON:000402370.46gold quality
nucleus accumbensUBERON:000188270.41gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.86

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

118 targeting ZNF391, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-12118100.0065.881270
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-432-3P100.0067.86705
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-3924100.0072.092394
HSA-MIR-3646100.0073.565283
HSA-MIR-223-3P99.9970.141140
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-1213699.9872.815713
HSA-MIR-548N99.9871.944170
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-185-3P99.9567.011743
HSA-MIR-391099.9571.132227
HSA-MIR-6809-3P99.9171.453814

Literature-anchored findings (GeneRIF, showing 1)

  • Spatial Expression Pattern of ZNF391 Gene in the Brains of Patients With Schizophrenia, Bipolar Disorders or Major Depressive Disorder Identifies New Cross-Disorder Biotypes: A Trans-Diagnostic, Top-Down Approach. (PMID:33822213)

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)

Protein

Protein identifiers

Zinc finger protein 391Q9UJN7 (reviewed: Q9UJN7)

All UniProt accessions (2): C9JUF8, Q9UJN7

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (4): NP_001070249, NP_001309217, NP_001309218, NP_001309222 (=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096

UniProt features (17 total): zinc finger region 9, compositionally biased region 3, region of interest 2, sequence variant 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9UJN7-F176.740.65

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 81 (showing top): BROWNE_HCMV_INFECTION_12HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ALKBH3_TARGET_GENES, ARNT2_TARGET_GENES, CBX5_TARGET_GENES, CHAMP1_TARGET_GENES, CREB3L4_TARGET_GENES, DIDO1_TARGET_GENES, GLI4_TARGET_GENES, HES2_TARGET_GENES, HMG20B_TARGET_GENES, KLF14_TARGET_GENES, KLF7_TARGET_GENES, RLF_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

244 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF391KRABD4Q5JUW0638
ZNF391OR2H1Q9GZK4574
ZNF391SAPCD1Q5SSQ6542
ZNF391LRRC36Q1X8D7400
ZNF391SPRYD4Q8WW59399
ZNF391C5orf34Q96MH7399
ZNF391GBX1Q14549358
ZNF391MRPS11P82912356
ZNF391CALHM2Q9HA72349
ZNF391ABHD3Q8WU67335
ZNF391NELFEP18615323
ZNF391TMEM178AQ8NBL3322
ZNF391MRPL42Q9Y6G3320
ZNF391PNPLA7Q6ZV29314
ZNF391SLC25A26Q70HW3311
ZNF391PTOV1Q86YD1311

IntAct

0 interactions, top by confidence:

BioGRID (8): ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Affinity Capture-MS), ZNF391 (Affinity Capture-MS), ZNF391 (Affinity Capture-MS)

ESM2 similar proteins: A0JNB1, A6QLU5, O75123, O75820, P10076, P10755, P16374, P17031, P17097, P17141, P51814, Q02975, Q08ER8, Q14588, Q14590, Q32KN0, Q3V080, Q4V8A8, Q5CZA5, Q5R4K8, Q5R5Q6, Q5R9S5, Q5RBX0, Q61751, Q6GQR8, Q6P560, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q7Z3V5, Q8BLB0, Q8N141, Q8N184, Q8N823, Q8N8J6, Q8N9F8, Q8TBZ5, Q8TF47, Q96ND8

Diamond homologs: A0A087WUV0, Q96K75, Q99676, Q9HBT8, Q9UJL9, Q9UJN7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

49 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance39
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

600 predictions. Top by Δscore:

VariantEffectΔscore
6:27397583:G:GGdonor_gain0.9800
6:27397582:A:AGdonor_gain0.9700
6:27400292:GATA:Gacceptor_gain0.9700
6:27388877:G:GTdonor_gain0.9500
6:27399551:G:GGdonor_gain0.9500
6:27399547:CTTGG:Cdonor_loss0.9400
6:27399548:TTGGT:Tdonor_loss0.9400
6:27399549:TGGTG:Tdonor_loss0.9400
6:27399551:GT:Gdonor_loss0.9400
6:27399552:T:TAdonor_loss0.9400
6:27399553:GAGTA:Gdonor_loss0.9400
6:27399554:AG:Adonor_loss0.9400
6:27399555:G:Adonor_loss0.9400
6:27388983:T:TAdonor_gain0.9200
6:27399436:CTGCA:Cacceptor_loss0.9200
6:27399437:TGCA:Tacceptor_loss0.9200
6:27399438:GCAGG:Gacceptor_loss0.9200
6:27399439:CA:Cacceptor_loss0.9200
6:27399440:A:Gacceptor_loss0.9200
6:27399441:G:Cacceptor_loss0.9200
6:27400287:TTTCA:Tacceptor_loss0.9200
6:27400288:TTCA:Tacceptor_loss0.9200
6:27400289:TCAGA:Tacceptor_loss0.9200
6:27400291:AG:Aacceptor_loss0.9200
6:27388925:TTCG:Tdonor_gain0.9100
6:27388984:T:Adonor_gain0.9100
6:27399556:T:Gdonor_loss0.9100
6:27389043:GGTG:Gdonor_loss0.9000
6:27389044:G:GAdonor_loss0.9000
6:27389045:T:TTdonor_loss0.9000

AlphaMissense

2387 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:27400890:T:CF174L0.998
6:27400892:T:AF174L0.998
6:27400892:T:GF174L0.998
6:27400974:T:CF202L0.998
6:27400976:T:AF202L0.998
6:27400976:T:GF202L0.998
6:27400806:T:CF146L0.997
6:27400808:C:AF146L0.997
6:27400808:C:GF146L0.997
6:27401310:T:CF314L0.996
6:27401312:C:AF314L0.996
6:27401312:C:GF314L0.996
6:27401394:T:CF342L0.996
6:27401396:C:AF342L0.996
6:27401396:C:GF342L0.996
6:27400897:G:CR176P0.995
6:27401142:T:CF258L0.995
6:27401144:C:AF258L0.995
6:27401144:C:GF258L0.995
6:27400825:T:CL152P0.994
6:27400981:G:CR204P0.994
6:27400993:T:CL208P0.994
6:27401003:T:AH211Q0.994
6:27401003:T:GH211Q0.994
6:27400813:G:CR148P0.993
6:27400835:T:AH155Q0.993
6:27400835:T:GH155Q0.993
6:27400891:T:CF174S0.993
6:27401008:G:CR213P0.993
6:27401058:T:CF230L0.993

dbSNP variants (sampled 300 via entrez): RS1000018252 (6:27372807 G>A), RS1000164453 (6:27401337 C>T), RS1000220226 (6:27388971 A>G,T), RS1000263524 (6:27393621 C>T), RS1000308850 (6:27402091 G>C), RS1000335921 (6:27381519 G>A,T), RS1000337516 (6:27393988 T>C), RS1000841722 (6:27381188 G>A), RS1001096943 (6:27374969 T>A), RS1001384925 (6:27388209 A>G), RS1001427217 (6:27374665 C>G), RS1001566301 (6:27402843 C>T), RS1001572538 (6:27378583 C>T), RS1001580246 (6:27403671 T>G), RS1001663818 (6:27397067 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

21 associations (top):

StudyTraitp-value
GCST004521_116Autism spectrum disorder or schizophrenia3.000000e-16
GCST004521_166Autism spectrum disorder or schizophrenia4.000000e-24
GCST004521_254Autism spectrum disorder or schizophrenia6.000000e-11
GCST004521_57Autism spectrum disorder or schizophrenia1.000000e-20
GCST004521_69Autism spectrum disorder or schizophrenia8.000000e-24
GCST004521_73Autism spectrum disorder or schizophrenia8.000000e-11
GCST006948_35Feeling nervous5.000000e-08
GCST008921_6Asthma and major depressive disorder1.000000e-09
GCST008921_9Asthma and major depressive disorder3.000000e-08
GCST010002_50Refractive error4.000000e-34
GCST010142_16Fish- and plant-related diet2.000000e-10
GCST010142_19Fish- and plant-related diet4.000000e-10
GCST010142_34Fish- and plant-related diet7.000000e-09
GCST010142_35Fish- and plant-related diet8.000000e-09
GCST010142_42Fish- and plant-related diet1.000000e-08
GCST010142_7Fish- and plant-related diet3.000000e-12
GCST010702_75Subcortical volume (MOSTest)3.000000e-11
GCST010703_272Brain morphology (MOSTest)7.000000e-16
GCST90011899_28Aspartate aminotransferase levels8.000000e-30
GCST90011900_180Serum alkaline phosphatase levels1.000000e-10
GCST90016674_15Liver iron content2.000000e-29

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0009597feeling nervous measurement
EFO:0008111diet measurement
EFO:0004346neuroimaging measurement
EFO:0004736aspartate aminotransferase measurement
EFO:0004533alkaline phosphatase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteaffects methylation, decreases expression, affects cotreatment, increases abundance, increases expression3
Valproic Aciddecreases expression3
bisphenol Adecreases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
manganese chlorideaffects cotreatment, increases abundance, increases expression1
perfluorooctane sulfonic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
bisphenol Saffects cotreatment, decreases methylation1
(+)-JQ1 compounddecreases expression1
Fulvestrantdecreases methylation, affects cotreatment1
Acetaminophendecreases expression1
Arsenicaffects cotreatment, increases abundance, increases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Tetrachlorodibenzodioxinincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Antirheumatic Agentsdecreases expression1
Cadmium Chloridedecreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_HD24HEK293 eGFP-ZNF391Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.